{
  "id": 1768,
  "text": "Observed toxicities were similar in severity and frequency based on previous experiences with these compounds.In a secondary analysis of patients that had not received prior platinum, the cisplatin/paclitaxel doublet appeared to be superior to carboplatin/paclitaxel with a median OS of 23.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Observed toxicities were similar in severity and frequency based on previous experiences with these compounds.In a secondary analysis of patients that had not received prior platinum, the cisplatin/paclitaxel doublet appeared to be superior to carboplatin/paclitaxel with a median OS of 23.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "如果患者没有接受过铂类药物治疗，对于宫颈癌的治疗，顺铂/紫杉醇组合显示出比卡铂/紫杉醇组合更优越的效果，具体表现为顺铂/紫杉醇组合具有更长的中位总生存期（OS）。",
  "query": "如果患者没有接受过铂类药物治疗，顺铂/紫杉醇组合与卡铂/紫杉醇组合相比，哪种治疗方案显示出更优越的效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 如果患者没有接受过铂类药物治疗，顺铂/紫杉醇组合与卡铂/紫杉醇组合相比，哪种治疗方案显示出更优越的效果？\n\n<reference text>: Observed toxicities were similar in severity and frequency based on previous experiences with these compounds.In a secondary analysis of patients that had not received prior platinum, the cisplatin/paclitaxel doublet appeared to be superior to carboplatin/paclitaxel with a median OS of 23.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "如果患者没有接受过铂类药物治疗，对于宫颈癌的治疗，顺铂/紫杉醇组合显示出比卡铂/紫杉醇组合更优越的效果，具体表现为顺铂/紫杉醇组合具有更长的中位总生存期（OS）。"
}